A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 411,727 shares of GILD stock, worth $37 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
411,727
Previous 547,324 24.77%
Holding current value
$37 Million
Previous $37.6 Million 8.1%
% of portfolio
0.07%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$66.59 - $83.99 $9.03 Million - $11.4 Million
-135,597 Reduced 24.77%
411,727 $34.5 Million
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $73 Million - $84.2 Million
-1,155,415 Reduced 67.86%
547,324 $37.6 Million
Q1 2024

May 14, 2024

SELL
$71.58 - $87.29 $42.6 Million - $52 Million
-595,546 Reduced 25.91%
1,702,739 $125 Million
Q4 2023

Feb 14, 2024

SELL
$73.27 - $83.09 $65.1 Million - $73.8 Million
-887,874 Reduced 27.87%
2,298,285 $186 Million
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $14.4 Million - $15.7 Million
194,210 Added 6.49%
3,186,159 $239 Million
Q2 2023

Aug 14, 2023

SELL
$76.01 - $86.7 $10.5 Million - $12 Million
-138,750 Reduced 4.43%
2,991,949 $231 Million
Q1 2023

May 12, 2023

BUY
$77.31 - $88.08 $7.58 Million - $8.64 Million
98,039 Added 3.23%
3,130,699 $260 Million
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $117 Million - $168 Million
1,874,836 Added 161.93%
3,032,660 $260 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $10.3 Million - $11.7 Million
172,593 Added 17.52%
1,157,824 $71.4 Million
Q2 2022

Aug 12, 2022

BUY
$57.72 - $65.01 $4.9 Million - $5.52 Million
84,900 Added 9.43%
985,231 $60.9 Million
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $21.3 Million - $26.6 Million
367,100 Added 68.84%
900,331 $53.5 Million
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $5.79 Million - $6.57 Million
-89,200 Reduced 14.33%
533,231 $38.7 Million
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $7.01 Million - $7.57 Million
103,600 Added 19.97%
622,431 $43.5 Million
Q2 2021

Aug 13, 2021

BUY
$63.47 - $69.35 $12.2 Million - $13.3 Million
191,655 Added 58.58%
518,831 $35.7 Million
Q1 2021

May 14, 2021

BUY
$60.0 - $68.46 $7.8 Million - $8.9 Million
130,016 Added 65.94%
327,176 $21.1 Million
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $8.48 Million - $9.66 Million
-149,702 Reduced 43.16%
197,160 $11.5 Million
Q3 2020

Nov 13, 2020

SELL
$62.1 - $78.08 $2.44 Million - $3.06 Million
-39,239 Reduced 10.16%
346,862 $21.9 Million
Q2 2020

Aug 14, 2020

SELL
$72.34 - $84.0 $10.7 Million - $12.4 Million
-147,800 Reduced 27.68%
386,101 $29.7 Million
Q1 2020

May 14, 2020

BUY
$62.63 - $80.22 $6.49 Million - $8.32 Million
103,700 Added 24.11%
533,901 $39.9 Million
Q4 2019

Feb 14, 2020

SELL
$61.62 - $67.78 $3.56 Million - $3.92 Million
-57,800 Reduced 11.84%
430,201 $28 Million
Q3 2019

Nov 14, 2019

BUY
$62.51 - $69.0 $875,140 - $966,000
14,000 Added 2.95%
488,001 $30.9 Million
Q2 2019

Aug 09, 2019

SELL
$61.87 - $69.38 $6.76 Million - $7.58 Million
-109,300 Reduced 18.74%
474,001 $32 Million
Q1 2019

May 14, 2019

SELL
$62.53 - $70.05 $2.24 Million - $2.51 Million
-35,900 Reduced 5.8%
583,301 $37.9 Million
Q4 2018

Feb 14, 2019

SELL
$60.54 - $79.0 $11 Million - $14.4 Million
-181,700 Reduced 22.69%
619,201 $38.7 Million
Q3 2018

Nov 14, 2018

SELL
$71.28 - $78.92 $1.45 Million - $1.61 Million
-20,400 Reduced 2.48%
800,901 $61.8 Million
Q2 2018

Aug 13, 2018

SELL
$64.88 - $75.68 $58 Million - $67.7 Million
-893,914 Reduced 52.12%
821,301 $58.2 Million
Q1 2018

May 14, 2018

SELL
$72.84 - $88.8 $6.55 Million - $7.98 Million
-89,886 Reduced 4.98%
1,715,215 $129 Million
Q4 2017

Feb 13, 2018

SELL
$71.15 - $83.52 $26.3 Million - $30.9 Million
-369,800 Reduced 17.0%
1,805,101 $129 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $157 Million - $186 Million
2,174,901
2,174,901 $177 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.